Based on all the information presented above, TP63 and FOXO1 suppress prostate cancer lineage plasticity through the RTK/RAS pathway, whereas RORC drives prostate cancer lineage plasticity through RTK/RAS pathway. Here, RORC is linked to prostate carcinoma.